DAX-1 protein, methods for production and use thereof
    1.
    发明授权
    DAX-1 protein, methods for production and use thereof 失效
    DAX-1蛋白,其生产和使用方法

    公开(公告)号:US06465627B2

    公开(公告)日:2002-10-15

    申请号:US08687691

    申请日:1996-07-26

    IPC分类号: C12N1511

    摘要: The invention provides a DAX-1 protein molecule having the amino acid sequence beginning with methionine at position 1 and ending with isoleucine at position 470 as shown in FIG. 12. The invention further provides the genomic nucleic acid sequence for DAX-1, including intron, exons and a promoter region. Additionally, the invention provides methods for using and making the DAX-1 protein and DAX-1 nucleic acid molecules.

    摘要翻译: 本发明提供了一种DAX-1蛋白质分子,其具有如图1所示的氨基酸序列,起始于位置1处的甲硫氨酸和位置470的异亮氨酸结束。 本发明还提供了DAX-1的基因组核酸序列,包括内含子,外显子和启动子区。 此外,本发明提供了使用和制备DAX-1蛋白和DAX-1核酸分子的方法。

    Benzoxazinones as peroxisome proliferator activated receptor gamma modulators and method of treatment
    4.
    发明授权
    Benzoxazinones as peroxisome proliferator activated receptor gamma modulators and method of treatment 有权
    苯并恶嗪酮作为过氧化物酶体增殖物激活受体γ调节剂及其治疗方法

    公开(公告)号:US06599899B2

    公开(公告)日:2003-07-29

    申请号:US09853798

    申请日:2001-05-11

    IPC分类号: A61K31536

    CPC分类号: C07D265/36

    摘要: The invention is directed to benzoxazinone derivatives useful as peroxisome proliferator activated receptor gamma (PPAR&ggr;) modulators. Pharmaceutical compositions comprising compounds of the present invention and methods of treating conditions such as NIDDM and obesity are also disclosed.

    摘要翻译: 本发明涉及可用作过氧化物酶体增殖物激活受体γ(PPARγ)调节剂的苯并恶嗪酮衍生物。 还公开了包含本发明化合物的药物组合物和治疗诸如NIDDM和肥胖症的病症的方法。